Skip to main content
Premium Trial:

Request an Annual Quote

SRA Gets NIAID Contract to Develop Database for Bioterror Research

NEW YORK, July 15 (GenomeWeb News) - Information technology services firm SRA International announced today that it has been awarded a five-year contract by the National Institute of Allergy and Infectious Diseases to develop a Web-based database system to collect, store, and analyze data used by biomedical researchers in their study of biodefense and public health.

 

The contract was awarded to SRA subsidiary Systems Research and Applications Corporation and has an estimated value of $13.6 million. The database will consolidate known information about enterobacteria, a group of pathogens that can cause dysentery, plague, food poisoning, and typhoid fever.

 

NIAID, which is part of the National Institutes of Health, selected Fairfax, Va.-based SRA to develop and operate the database to enhance knowledge sharing, analyze data, and improve the quality and reuse of genomic research data, according to SRA. The SRA team includes staff from the Genome Center of the University of Wisconsin - Madison, which will advise SRA on bioinformatics tools and user interfaces.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.